Home/Filings/4/0001415889-24-001545
4//SEC Filing

Wingrove Theresa 4

Accession 0001415889-24-001545

CIK 0000855654other

Filed

Jan 17, 7:00 PM ET

Accepted

Jan 18, 6:28 PM ET

Size

16.7 KB

Accession

0001415889-24-001545

Insider Transaction Report

Form 4
Period: 2024-01-16
Wingrove Theresa
VP of Regulatory Affairs
Transactions
  • Exercise/Conversion

    Common Stock

    2024-01-16$4.83/sh+58,900$284,48762,326 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-01-16126,1000 total
    Exercise: $5.25Exp: 2029-01-31Common Stock (126,100 underlying)
  • Exercise/Conversion

    Common Stock

    2024-01-16$5.25/sh+126,100$662,025191,093 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-01-1658,9000 total
    Exercise: $4.83Exp: 2029-02-05Common Stock (58,900 underlying)
  • Exercise/Conversion

    Common Stock

    2024-01-16$5.75/sh+2,667$15,33564,993 total
  • Sale

    Common Stock

    2024-01-16$29.64/sh187,667$5,562,4503,426 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-01-162,6671,333 total
    Exercise: $5.75Exp: 2026-06-01Common Stock (2,667 underlying)
Footnotes (5)
  • [F1]Effected pursuant to a trading plan adopted on June 13, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  • [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.60 to $29.71, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.
  • [F3]This option was granted on 2/5/2019 and is fully vested as of the date of this transaction.
  • [F4]This option was granted on 6/01/2016 and is fully vested as of the date of this transaction.
  • [F5]This option was granted on 01/31/2019 and is fully vested as of the date of this transaction.

Issuer

ImmunoGen, Inc.

CIK 0000855654

Entity typeother

Related Parties

1
  • filerCIK 0001510720

Filing Metadata

Form type
4
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 6:28 PM ET
Size
16.7 KB